University of Nebraska Medical Center: New Cystic Fibrosis Drug is Major Breakthrough for Patients
December 28, 2019
December 28, 2019
OMAHA, Nebraska, Dec. 28 -- The University of Nebraska Medical Center issued the following news release:
Medical breakthroughs never come easy. But, when they occur, the excitement they generate is extra special.
One of the biggest medical breakthroughs of 2019 took place in late October when the Food and Drug Administration approved a new drug (Trikafta) that will benefit 90% of cystic fibrosis patients - those with the most common mutation (delta-F508) to the CFTR gen . . .
Medical breakthroughs never come easy. But, when they occur, the excitement they generate is extra special.
One of the biggest medical breakthroughs of 2019 took place in late October when the Food and Drug Administration approved a new drug (Trikafta) that will benefit 90% of cystic fibrosis patients - those with the most common mutation (delta-F508) to the CFTR gen . . .